ArticleNature reviews. Cardiology2014

Dyslipidaemia: 1-Year results from OSLER trial of anti-PCSK9 monoclonal antibody evolocumab.

Bryony M MearnsPubMed ↗Publisher ↗

No numbers read from the abstract.